Skip to Main content Skip to Navigation
Journal articles

Challenges of Gene Therapy for the Treatment of Glycogen Storage Diseases Type I and Type III

Abstract : Glycogen storage diseases (GSDs) type I (GSDI) and type III (GSDIII), the most frequent hepatic GSDs, are due to defects in glycogen metabolism, mainly in the liver. In addition to hypoglycemia and liver pathology, renal, myeloid, or muscle complications affect GSDI and GSDIII patients. Currently, patient management is based on dietary treatment preventing severe hypoglycemia and increasing the lifespan of patients. However, most of the patients develop long-term pathologies. In the past years, gene therapy for GSDI has generated proof of concept for hepatic GSDs. This resulted in a recent clinical trial of adeno-associated virus (AAV)-based gene replacement for GSDIa. However, the current limitations of AAV-mediated gene transfer still represent a challenge for successful gene therapy in GSDI and GSDIII. Indeed, transgene loss over time was observed in GSDI liver, possibly due to the degeneration of hepatocytes underlying the physiopathology of both GSDI and GSDIII and leading to hepatic tumor development. Moreover, multitissue targeting requires high vector doses to target nonpermissive tissues such as muscle and kidney. Interestingly, recent pharmacological interventions or dietary regimen aiming at the amelioration of the hepatocyte abnormalities before the administration of gene therapy demonstrated improved efficacy in GSDs. In this review, we describe the advances in gene therapy and the limitations to be overcome to achieve efficient and safe gene transfer in GSDs.
Document type :
Journal articles
Complete list of metadata

Cited literature [97 references]  Display  Hide  Download
Contributor : Marie-Ange Di Carlo Connect in order to contact the contributor
Submitted on : Monday, November 25, 2019 - 3:22:18 PM
Last modification on : Wednesday, April 13, 2022 - 5:52:01 PM
Long-term archiving on: : Wednesday, February 26, 2020 - 8:22:30 PM


 Restricted access
To satisfy the distribution rights of the publisher, the document is embargoed until : jamais

Please log in to resquest access to the document



Louisa Jauze, Laure Monteillet, Gilles Mithieux, Fabienne Rajas, Giuseppe Ronzitti. Challenges of Gene Therapy for the Treatment of Glycogen Storage Diseases Type I and Type III. Human Gene Therapy, Mary Ann Liebert, 2019, 30 (10), pp.1263-1273. ⟨10.1089/hum.2019.102⟩. ⟨inserm-02379154⟩



Record views